Purchase Order 75N92B24P00094

Award Date 7/30/24
Potential Completion Date 7/29/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Haven, CT 06519, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,000 firm fixed-price purchase order contract awarded to Atlasxomics Inc. by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency. The contract is for the delivery of hardware starter kits, sample optimization kits, and spatial ATAC-seq kits to support the agency's genomics and cancer research. Atlasxomics is a biotechnology company that specializes in spatial multi-omics technologies, including its proprietary Deterministic Barcoding in...
Atlasxomics Inc. has been awarded a $21,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases to provide laboratory and testing services in support of the agency's research programs. The contract has a period of performance of just over one year, running from December 2023 through December 2024. Work will be conducted by Atlasxomics at its New Haven, Connecticut facility. No major subcontractors or set...
This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation. 10X Genomics is providing specialized scientific equipment,...
This is a $52,500.00 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Atlasxomics Inc., a biotechnology company specializing in spatial multi-omics technologies. The contract is for ATAC sequencing analysis of 15 samples, which supports NCI's research into chromatin accessibility and gene regulation in cancer. The original contract opportunity was a sole-source procurement for Atlasxomics' proprietary...
This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
This firm fixed price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to 10X Genomics, Inc., a life sciences technology company, with a potential value of $12,164.00. The contract has a completion date of May 15, 2025 and was awarded on May 16, 2024. The award is not associated with a set-aside designation. Under this contract, 10X Genomics will provide the NIH with specialized kits, instruments, and...
This is a $11,000 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The contract is not set aside and does not appear to be part of a larger contract vehicle. Under this contract, 10X Genomics will provide specialized scientific equipment,...
This is a $85,912.20 firm-fixed-price delivery order issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services. The order was awarded to Astrix Technology LLC, a for-profit limited liability company, to provide support for multiple data-heavy research projects from over 20 labs across various stages of biomedical research. This includes working with large-scale data from genomic data types such...
This firm fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences, a component of the National Institutes of Health within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,349.00 award is for the delivery of 10X Genomics' specialized kits, instruments, and associated services to support biomedical research activities. The contract does not have a set-aside designation. As a prime contractor, 10X Genomics has...
The National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $95,312 firm fixed price purchase order contract to 10X Genomics, Inc. for the purchase of a 10X Genomics Chromium X instrument. The contract is in response to a brand name or equal solicitation seeking a 10X Genomics Chromium X for use at NIAMS. 10X Genomics will deliver one Chromium X system to the agency's location in Pleasanton, California by September 24, 2022 to support...

This $22,000 firm fixed-price purchase order contract was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), to Atlasxomics Inc., a biotechnology company specializing in spatial multi-omics technologies. The contract is for the delivery of hardware starter kits, sample optimization kits, and spatial ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) kits to support NIAMS' research into chromatin accessibility and gene regulation, particularly in the areas of arthritis, musculoskeletal conditions, and skin diseases. No set-aside designation was indicated. This contract is one of several federal awards, including grants, that Atlasxomics has received to further develop and commercialize its innovative spatial biology platforms for applications in genomics and cancer research.

Generated 7/31/24, 9:07 AM